132 related articles for article (PubMed ID: 11392255)
1. [Fungal infections in intensive care units: a cross-survey].
Dupont H
Ann Fr Anesth Reanim; 2001 Apr; 20(4):413-7. PubMed ID: 11392255
[TBL] [Abstract][Full Text] [Related]
2. [Infections by Candida sp. in intensive care. Survey of French practices].
Gauzit R; Cohen Y; Dupont H; Hennequin C; Montravers P; Timsit JF; Veber B; Chevalier E; Blin P; Palestro B
Presse Med; 2003 Mar; 32(10):440-9. PubMed ID: 12733304
[TBL] [Abstract][Full Text] [Related]
3. [Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Alvarez-Lerma F; Nolla J; Palomar M; León MA
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):83-8. PubMed ID: 12586031
[TBL] [Abstract][Full Text] [Related]
4. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
5. [Indications for antifungal treatment in intensive care unit patients].
Alvarez-Lerma F; Palomar M; León C; Olaechea P; Cerdá E; Bermejo B;
Enferm Infecc Microbiol Clin; 2004 May; 22(5):279-85. PubMed ID: 15207119
[TBL] [Abstract][Full Text] [Related]
6. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
7. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM
Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
[TBL] [Abstract][Full Text] [Related]
9. Management of systemic candidal infections in the intensive care unit.
Kam LW; Lin JD
Am J Health Syst Pharm; 2002 Jan; 59(1):33-41. PubMed ID: 11813465
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
Ding CH; Wahab AA; Muttaqillah NA; Tzar MN
J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581
[TBL] [Abstract][Full Text] [Related]
11. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
Infection; 1996; 24(6):426-32. PubMed ID: 9007589
[TBL] [Abstract][Full Text] [Related]
12. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.
Berrouane YF; Herwaldt LA; Pfaller MA
J Clin Microbiol; 1999 Mar; 37(3):531-7. PubMed ID: 9986807
[TBL] [Abstract][Full Text] [Related]
13. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
14. [Yeast urinary tract infections. Multicentre study in 14 hospitals belonging to the Buenos Aires City Mycology Network].
Maldonado I; Arechavala A; Guelfand L; Relloso S; Garbasz C;
Rev Iberoam Micol; 2016; 33(2):104-9. PubMed ID: 26810887
[TBL] [Abstract][Full Text] [Related]
15. Identification and antifungal susceptibility of Candida isolated from intensive care unit patients.
Zer Y; Balci I; Meriç G
New Microbiol; 2002 Oct; 25(4):489-94. PubMed ID: 12437230
[TBL] [Abstract][Full Text] [Related]
16. Invasive candidiasis in the intensive care unit.
Krishnan S; Ostrosky-Zeichner L
Hosp Pract (1995); 2010 Apr; 38(2):82-91. PubMed ID: 20469617
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
18. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
20. Surgical critical care: fungal infections in surgical patients.
Lipsett PA
Crit Care Med; 2006 Sep; 34(9 Suppl):S215-24. PubMed ID: 16917426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
